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Abstract
Sphingolipids are a family of eukaryotic lipids biosynthesized from sphingoid
long-chain bases (LCBs). Sphingolipids are an essential class of lipids, as their
depletion results in cell death. However, acute LCB supplementation is also
toxic; thus, proper cellular LCB levels should be maintained. To characterize
the “sphingolipid-signaling intercross,” we performed a kinome screening assay
in which budding yeast protein kinase-knockout strains were screened for resis-
tance to ISP-1, a potent inhibitor of LCB biosynthesis. Here, one pair of such
DIR (deletion-mediated ISP-1 resistance) genes, FPK1 and FPK2, was further
characterized. Cellular LCB levels increased in the fpk1/2Δ strain, which was
hypersensitive to phytosphingosine (PHS), a major LCB species of yeast cells.
Concomitantly, this strain acquired resistance to ISP-1. Fpk1 and Fpk2 were
involved in two downstream events; that is, ISP-1 uptake due to aminophosp-
holipid flippase and LCB degradation due to LCB4 expression. RSK3, which
belongs to the p90-S6K subfamily, was identified as a functional counterpart of
Fpk1/2 in mammalian cells as the RSK3 gene functionally complemented the
ISP-1-resistant phenotype of fpk1/2Δ cells.
Introduction
Sphingolipids comprise a class of lipids that are biosynthe-
sized from sphingoid long-chain bases (LCBs), such as
phytosphingosine (PHS) (Fig. S1A; Dickson 1998). Given
the importance of sphingolipids for membrane biology,
the regulation of sphingolipid biosynthesis has attracted
much attention in the field of cell biology (Liu et al. 2005),
particularly in relation to cellular signaling under stress
conditions, such as heat stress (Dickson et al. 1997; Jenkins
et al. 1997; Cowart et al. 2003) in the yeast Saccharo-
myces cerevisiae (Buede et al. 1991; Nagiec et al. 1994).
Sphingolipids may also act as signaling molecules in the
control of the longevity of organisms (Huang et al. 2012).
However, information regarding the signaling aspects of
cellular sphingolipids remains largely fragmentary.
It has been suggested that LCBs, rather than complex
sphingolipids, are required for survival of yeast cells
(Schorling et al. 2001). However, it is not clear how a
lack of LCBs leads to lethal consequences. Recent studies
have indicated that endoplasmic reticulum stress could be
induced in sphingolipid-depleted cells (Kajiwara et al.
2012). In heat-stressed cells, LCBs may function as lipid
mediators to protect cells, controlling intracellular protein
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aggregation and translation (Meier et al. 2006; Cowart
et al. 2010). Cross-talk between LCB biosynthetic compo-
nents in cellular signaling has been investigated using
mutant cells that lack the proper sphingolipid profiles
(Zhao et al. 1994), as well as through the inhibition of
cellular serine palmitoyltransferase using the natural fun-
gal lipid ISP-1/myriocin (Kluepfel et al. 1972; Miyake
et al. 1995).
Cellular maintenance of LCB levels is important because
excess supplementation of PHS, a major LCB species in
yeast, causes acute G1 arrest of the cell cycle and subse-
quent cell death (Dickson and Lester 2002). This cell cycle
arrest could be related to LCB-mediated stress signaling
upon exposure of cells to elevated temperatures (Dickson
et al. 1997; Jenkins et al. 1997). Maintenance of proper
LCB levels is regulated, at least in part, by cell signaling
events. The serine/threonine protein kinase Ypk1/Sli2 (Sun
et al. 2000) was shown to play a major role in sphingo-
lipid homeostasis by phosphorylating Orm1/2 (Roelants
et al. 2011). Moreover, Orm1/2 phosphorylation, acting in
conjunction with the Pkh1/Ypk1 signaling cascade and
Cdc55-containing PP2A protein phosphatase, may func-
tion in biological regulatory circuits; for example, in the
heat stress response (Sun et al. 2012), during which LCB
species such as PHS are transiently induced. In fact, a
functional relationship between Ypk1 and LCBs was
revealed in which YPK1 was found to be a multicopy
repressor gene for ISP-1-mediated yeast lethality (Sun
et al. 2000). However, relatively little is known regarding
signaling events involving LCBs. Thus, further systematic
analyses on cellular signaling events regarding cellular
sphingolipids are required.
We probed the yeast “kinome” (Manning et al. 2002)
with ISP-1 to systematically screen for yeast kinase genes
that affect cell viability under conditions of sphingolipid
biosynthesis inhibition; this kinome screening was desig-
nated as gene deletion-mediated ISP-1 resistance (DIR).
We used this approach to increase our understanding of
the interrelationships between protein kinases and sphin-
golipids, including regulation of sphingolipids by kinase
(s) and vice versa. Using this method, we identified nine
protein kinase genes, deletion of which resulted in resis-
tance to ISP-1. The cellular LCB levels of each DIR
mutant were assayed to categorize the mutants. One par-
alogous set of DIR kinases, FPK1 and FPK2, was
functionally analyzed in detail. Fpk1/2 protein kinases
were originally reported as regulators of aminophospholi-
pid flippase (Nakano et al. 2008), and subsequently pro-
posed as substrates of Ypk1 (Roelants et al. 2010). We
found that Fpk1/2 redundantly functioned to suppress
basal LCB expression and control ISP-1 uptake. Thus,
mutation of FPK1/2 conferred concomitant resistance to
ISP-1 and sensitization to PHS. Our data indicated that
Fpk1/2 kinases play a role in maintaining appropriate cel-
lular LCB levels. We also found that mammalian RSK3,
which belongs to the p90-S6K kinase family, was a func-
tional counterpart of Fpk1/2 based on the results of
genetic complementation assays. These data are indicative




The anti-Ypk1 antibody was reported previously (Tanoue
et al. 2005). Antibodies against Fpk1 and Bap2 were
raised by immunization of a rabbit six times at 1-week
intervals with the recombinant N-terminal ~100 amino
acid residues conjugated to glutathione-S-transferase
(GST) (MBL, Nagoya, Japan). Anti-Lcb4 rabbit antiserum
was kindly provided by Dr. Akio Kihara (Hokkaido Uni-
versity). The anti-PGK1 antibody, HA, and GST were
from Invitrogen (Life Technologies, Grand Island, NY),
Covance (Princeton, NJ) and Upstate Biotechnology
(Lake Placid, NY), respectively. The HRP-conjugated
anti-mouse and anti-rabbit goat IgG were from Zymed
(Life Technologies) and DAKO (Glostrup, Denmark),
respectively.
Yeast strains, culture conditions, and
reagents
The yeast strains used in this study are listed in Table S3.
Mutant strains and isogenic control strains were main-
tained on synthetic defined (SD) plates (Giaever et al.
2002). The conditions for cell culture were as reported
previously (Kobayashi et al. 2005). Briefly, fresh colonies
were inoculated into YPD medium and incubated over-
night, unless otherwise stated. Overnight cultures of yeast
cells were diluted to an optical density at 600 nm
(OD600) of 0.2 in YPD medium and cultured. Cell
growth was monitored by OD600 measurements. Cells in
the logarithmic phase of growth were used. SR medium
(6.7 g of yeast nitrogen base without amino acids [Difco,
Detroit, MI] plus 20 g of raffinose per liter) was used for
induction of the GAL1 promoter. Duramycin (Sigma
Chemical Co., St. Louis, MO) was dissolved in water.
ISP-1/myriocin (Sigma) was dissolved in methanol, and
PHS (Sigma) and stearylamine (Sigma) were dissolved in
ethanol. Aureobasidin A and dihydrosphingosines were
dissolved in ethanol and methanol, respectively. Cells
were treated with PHS (20 lM) and incubated for 15 or
30 min prior to harvesting. Treatment with ISP-1 (500–
750 ng mL1) was performed as described previously
(Sun et al. 2000).
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Plasmid and yeast strain construction
Construction of the deletion strains was achieved
through PCR-based homologous recombination, as
described previously (Brachmann et al. 1998; Longtine
et al. 1998). For strain ypk1S71A, a point mutation was
introduced into YPK1 in YEp351 by site-directed muta-
genesis (Clontech Laboratories, Palo Alto, CA). The
mutant YPK1 fragment was then ligated into pFA6a-
HIS3MX6 to generate a “knock-in” plasmid. PCR-ampli-
fied ypk1S71A-HISMX6 was transformed into BY4741
cells, and the transformants were selected for homolo-
gous recombination. To achieve gene overexpression,
FPK1 was cloned into YEp352. FPK2 and YPK1 were
cloned into YEp351. PGAL1-GST-YPK1 was kindly pro-
vided by Dr. Jason Ptacek (Yale University) (Zhu et al.
2000). For overexpression of GST-Fpk1/2 in yeast cells, a
fragment that contained GST-FPK1 and GST-FPK2 was
placed under the control of the ADH1 promoter in
YEp351 and YEp352, respectively, as described previously
(Momoi et al. 2004). Human cDNA species for AGC
kinases were purchased from the MGC Clone Collection
(http://mgc.nci.nih.gov) and subcloned into the
pDONR221 vector using the BP reaction. The YEp351
vector harboring the ADH1 promoter and termination
signal with destination cassette was used to target the LR
reaction. The plasmid constructs and yeast strains used
in the present study are listed in Tables S3 and S4
(Shimobayashi et al. 2010).
DIR assay and other resistance assays
The expression of deletion-mediated ISP-1 resistance
(DIR) genes were determined using one-by-one ISP-1
resistance spot assays with serial 1:5 dilutions of cells on
YPD plates (Kobayashi et al. 2005). Briefly, each batch of
commercially available kinase-knockout cells (Research
Genetics, Huntsville, AL) (Table S1) was cultured in YPD
medium overnight and diluted to an OD600 of 0.2 in pre-
warmed fresh medium for 4 h to obtain early log-phase
cells. Cells were serially diluted and spotted onto YPD
plates that contained ISP-1 (500–750 ng mL1) or PHS
(30 lM) and incubated for 2–3 days. To avoid plate-by-
plate variability, we included at least one set of wild-type
(WT) control (BY4741) cells on each plate to evaluate
resistance to ISP-1. We defined resistant (DIR) strains as
those that grew more rapidly than the WT control when
WT cells were strongly attenuated on ISP-1-containing
plates. When SD plates were used elsewhere in this study,
the cells were spotted onto agar medium that contained
ISP-1 (500 ng mL1) or PHS (20 lM) and incubated for
3 days. To further evaluate ISP-1 resistance, OD600 values
after 24- or 36-h liquid culture were also determined for
strains identified as resistant by the plate-based assay.
LCB measurement
Extraction and processing of LCBs from yeast cells for
fluorescence high-performance liquid chromatography
(HPLC) analysis using the AQC reagent (Waters, Milford,
MS) were performed as described previously (Lester and
Dickson 2001; Sun et al. 2012). Briefly, HPLC analysis
was performed using a C18 column (4.6 9 250 mm,
XDB-C18; Hewlett-Packard, Palo Alto, CA) on a Shima-
dzu LC10A series liquid chromatography system. Isocratic
elution was carried out for 60 min at a flow rate of
1.0 mL min1. Lipid-reacted AQC reagent was excited
with 244-nm ultraviolet radiation, and the resultant emis-
sion signal at 398 nm was detected. C18-DHS and C18-
PHS were reacted with the AQC reagent and employed as
standards for quantification.
ISP-1 uptake assay
Yeast cells were cultured in YPD medium to the logarith-
mic growth phase, treated with 500 ng mL1 ISP-1 for
1.5 h, and then harvested and washed with water. Yeast
cells were suspended in 0.1 M KCl, and the cell suspen-
sion was vortexed six times for 30 sec with a half-volume
of glass beads, and then the mixture was adjusted to a
final acetic acid concentration of 0.1 M. ISP-1 in the
lysate was extracted by successive addition and mixing of
reagents as follows: (1) 2.5 volumes of methanol and 1.25
volumes of chloroform with 10 min of shaking; and (2)
1.25 volumes of chloroform and 1.25 volumes of water
with overnight shaking at 4°C. The phases were separated
by centrifugation, and the organic phase was recovered,
dried, and resuspended in 60 mM triethylamine/metha-
nol. HPLC analysis was performed using a C18 column
(4.6 9 250 mm, XDB-C18; Hewlett-Packard) on a Shi-
madzu LC10A series liquid chromatography system using
gradient elution with a total flow rate of 1.0 mL min1.
Solution A contained 1.73 g of CH3COONa-3H2O,
0.55 mL of phosphoric acid and 0.09 mL of triethylamine
per liter, and Solution B consisted of 60% acetonitrile.
The timeline for gradient elution was as follows: 0–
20 min, Solution A, 90–67%; 20–50 min, Solution A, 67–
0%; and 50–70 min, Solution A, 0%. Lipid-reacted AQC
reagent was detected as in the LCB measurements. ISP-1
reacted with the AQC reagent (AQC-ISP-1) was eluted at
44.8 min. This peak was further evaluated by MALDI-
TOF-MS analysis, whereby the expected sizes
([M+H]+ = 572.2 m/z; [M+Na]+ = 594.1 m/z) were con-
firmed. Therefore, this peak was employed as the standard
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for quantification. The concentration of ISP-1 was nor-
malized to the OD600 value of each strain.
Western blotting
Whole-cell extracts were prepared from logarithmically
growing cells. Yeast cells were harvested and resuspended
in lysis buffer (50 mM Tris-HCl, pH 7.5, 0.5 mM EGTA,
1.5 mM MgCl2, 1 mM PMSF, protease inhibitor cocktail
[Nacalai Tesque, Kyoto, Japan], 5 mM dithiothreitol,
25 mM b-glycerophosphate, 50 mM NaF, 0.5% Triton X-
100). To lyse yeast cells, the cell suspension was vortexed
with a half-volume of glass beads, as described previously
(Momoi et al. 2004). Unbroken cells and debris were
removed by centrifugation at 800g for 5 min, and the su-
pernatants were treated with SDS-PAGE (sodium dodecyl
sulfate polyacrylamide gel electrophoresis) sample buffer
and boiled for 5 min for denaturation. Protein concentra-
tions were determined using a Bio-Rad protein assay kit
(Hercules, CA). In standard SDS-PAGE (7.5% acrylamide)
and Western blotting, 30 lg of protein per lane for Ypk1
and Pgk1 were loaded on the gels. The endogenous levels
of Ypk1, Fpk1, Lcb4, and Bap2 were detected using a poly-
clonal antibody specific for each protein (Iwaki et al. 2005;
Tanoue et al. 2005). GST-Ypk1 and GST-Fpk1/2 were
visualized using rabbit antibodies directed against GST
(Upstate Biotechnology). A chemiluminescent substrate,
Chemilumi-One (Nacalai Tesque), and LAS-4000 Mini
(Fujifilm, Tokyo, Japan) were used for signal detection. To
quantify protein abundance, we measured the signal inten-
sities of the bands, and the signals were normalized relative
to that of Pgk1 as a loading control using the ImageGage
software (Fujifilm).
In vitro kinase assay
Cells that overexpressed GST-Fpk1 or/and GST-Fpk2
under the control of the ADH1 promoter were lysed, and
the GST-fusion proteins were precipitated by glutathione-
Sepharose 4B (GE Healthcare, Little Chalfont, UK). GST-
fusion proteins isolated from total lysates (400 lg pro-
tein) of yeast cells were used in the reaction. Recombi-
nant GST-Ypk1 (WT or the 71A mutant) was expressed
in Escherichia coli, isolated using a column of glutathione-
Sepharose 4B and eluted with glutathione, as reported
previously (Tanoue et al. 2005). GST-Ypk1 (20 lg) was
used in the reaction, unless otherwise stated. The kinase
reaction (100 lL) was performed in kinase buffer
(25 mM Tris-HCl, pH 7.5, 5 mM b-glycerophosphate,
2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2). The reac-
tion was started by addition of 10 lL of a solution con-
taining 50 lM cold ATP, 3 lCi [c-32P]-ATP, and 10 mM
MgCl2, incubated for 30 min at 30°C with tapping at 3-
min intervals, and terminated with the addition of 59
SDS-PAGE sample buffer. The samples were heated to
98°C for 5 min. The proteins were separated by SDS-
PAGE, and the gel was subsequently dried. Phosphory-
lated bands were detected by autoradiography using BAS-
2500 (Fujifilm). Proteins separated by SDS-PAGE were
also subjected to Western blotting using anti-GST anti-
bodies.
Determination of the phosphorylation site
on Ypk1 by liquid chromatography–tandem
mass spectrometry
Yeast cells harboring PGAL1-GST-YPK1 were grown to log
phase in SR medium, and GST-Ypk1 expression was
induced by addition of 4% galactose. PHS (20 lM) was
added to the medium, and the cells were cultured for
15 min before lysate preparation. The GST-fusion pro-
teins were bound to glutathione-Sepharose 4B resin and
subjected to SDS-PAGE. A retarded band corresponding
to phosphorylated Ypk1 was isolated from the Coomassie
brilliant blue (CBB)-stained gel. The band was subjected
to in-gel digestion with 12.5 ng mL1 trypsin. The result-
ing mixture was analyzed by LTQ (Thermo Electron,
Waltham, MS) liquid chromatography-tandem mass spec-
trometry (LC-MS/MS), and the corresponding proteins
were searched using the Mascot software (Matrix Science,
London, UK) (Hachiro et al. 2013), which is used to
identify proteins by matching mass spectroscopic data
with information from the National Center for Biotech-
nology Information (NCBI; http://www.ncbi.nlm.nih.gov)
and Swiss-Prot (http://us.expasy.org) protein databases.
Determination of duramycin resistance
Overnight-cultured yeast cells were diluted to an OD600
of 0.1 and then cultured at 30°C in preheated SD selective
medium for 1 h. For the spot assay, cells (2 lL) were
spotted in 10-fold serial dilutions on YPD plates that con-
tained duramycin (5 lg mL1). The plates were then
incubated at 30°C for 1.5 days. For the halo assay, over-
night-cultured yeast cells (~2 9 108) were plated on YPD
plates, and duramycin (1 mM) was then dropped onto
the plates. The plates were incubated for 3 days. Results
of duramycin resistance are shown in accordance with a
previous report to facilitate comparison (Roelants et al.
2010). However, resistance was not reproducible regard-
less of the assay (spot or halo) used.
DNA microarray
Auxotroph-matched BY4741-HIS3 control cells and fpk1/
2Δ cells were cultured to log phase, and mRNA was
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enriched using a combination of the hot phenol method
and an mTRAP mRNA Isolation kit (Active Motif,
Carlsbad, CA). The DNA microarray analysis was carried
out as reported previously (Koike et al. 2004), except
that a yeast cDNA microarray (Yeast Chip ver. 2-14;
DNA Chip Research Inc., Yokohama, Japan) was used.
The experiments adhered to the MIAME guidelines
(Brazma et al. 2001), and the obtained data were
submitted to the GEO database (http://www.ncbi.nlm.
nih.gov/geo/) under submission number GSE42083. Ext-
racted genes with expression levels that exhibited more
than twofold difference between samples are listed in
Table S2.
Metabolic labeling of de novo sphingolipid
biosynthesis
The sphingolipid profile of the fpk1/2Δ strain was exam-
ined by de novo labeling with [3H]-serine, as reported
previously (Sun et al. 2000). Briefly, log-phase cells were
labeled with [3H]-serine for 4 h. The sphingolipid frac-
tion was enriched and resolved by thin layer chromatog-
raphy (TLC). The radioactivity in each band was
visualized using a BAS2500 and tritium-imaging plates
(Fujifilm).
Results and Discussion
Deletion-mediated ISP-1 resistance (DIR)
ISP-1/myriocin treatment causes acute cellular sphingo-
lipid depletion, as ISP-1 is a potent inhibitor of serine
palmitoyltransferase, which is responsible for the first step
in sphingolipid biosynthesis (Miyake et al. 1995). Mam-
malian and yeast cells that are deprived of sphingolipids
undergo cell death upon ISP-1 treatment. Reversal of this
lethal phenotype can be exploited to screen for genes that
are involved in sphingolipid-mediated signal transduction.
Characterization of such kinase(s) will facilitate an
understanding of protein kinase signaling integration that
mediates generation of cellular sphingolipids, information
about which is limited at present. We carried out an assay
in which many protein kinases and several lipid
kinase-knockout cells were systematically assessed for
ISP-1 resistance. We spotted 105 commercially available
kinase-knockout strains on ISP-1 plates and compared
their resistance to that of the WT control strain on the
same plate. Nine DIR genes were isolated by screening
using serial dilution spotting on plates. This method
ensures that cells are treated at different densities to
examine ISP-1 resistance (Fig. 1A). We also observed a
similar resistance profile of these DIR mutants in a liquid



























































Figure 1. Identification of DIR genes. (A) ISP-1 resistance profiling of
the DIR genes. Kinase-knockout (DIR) cells and control BY4741 (WT)
cells were assessed for ISP-1 resistance on YPD-ISP-1 (750 ng mL1)
plates. The yeast culture was diluted serially as indicated and
incubated at 30°C for 3 days. Plate images were acquired using the
Printgraph camera system (ATTO, Tokyo, Japan). (B) LCB profiles of
DIR cells. The LCB profiles of the DIR strains were determined in
HPLC-based assays, as described in Experimental Procedures. The
cellular levels of C18-PHS (white box) and C18-DHS (gray box) are
expressed as incremented columns for each strain cultured in YPD
medium (top). The LCB levels after 3 h of treatment with
500 ng mL1 ISP-1 are also plotted (bottom). Each value shown is the
mean of three independent experiments, and the standard deviation
of error (SDE) for each experiment is indicated as a bar. Statistically
significance differences compared to the WT control were evaluated
using Student’s t test and are shown when P < 0.1.
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We expected that genetic screening of chemical com-
pounds would identify genes that modulate cell mem-
brane integrity. In the case of DIR screening, we selected
genes resistant to ISP-1. In fact, some of the DIR genes
had deletion phenotypes that indicated sensitivity to stress
conditions, listed in the Saccharomyces Genome Database
(http://www.yeastgenome.org/). In contrast, DIR strains
acquired resistance to ISP-1 despite a general membrane-
weakening phenotype, indicating that membrane integrity
has only a limited effect on the ISP-1-resistant phenotype
of these DIR strains (Table 1). We also identified knock-
out strains sensitive to ISP-1 (deletion-mediated ISP-1
vulnerability or DIV) (Table S1). We believe that loss of
membrane integrity (Levin 2005) could account for the
ISP-sensitivity of some DIV strains. However, loss of
membrane integrity is not the sole cause of changes in
ISP-1 sensitivity; DIV1/YPK1/SLI2 are also directly associ-
ated with cellular sphingolipids. The complete results of
ISP-1 resistance screening are presented in Table S1. Gen-
ome-wide chemical biology screening utilizing an array of
knockout cells has previously been reported (Hillenmeyer
et al. 2008). These genome-wide knockout strains (includ-
ing protein kinases) were treated with the compounds
(including ISP-1/myriocin A) for cellular fitness. When
their fitness defect values were compared to the ISP-1
resistance strength found in the present study, these two
assays generally agreed and the overall Pearson’s correla-
tion coefficient was positive (r > 0.36). Specifically, DIV
genes and their fitness defective genes showed stronger
agreement than DIR genes and gained fitness genes. As
the ISP-1 resistance assay was used to measure growth
differences, essential genes cannot be examined; therefore,
more sophisticated assays are required to examine the
entire kinome. Moreover, the presence of redundancy
between similar kinases makes it difficult to detect poten-
tial links between sphingolipids. Probably for this reason,
our screening assay did not identify PKH1/2 as DIV
genes, although Pkh1/2 was shown to be involved in
sphingolipid-mediated signaling event(s) (Friant et al.
2001; Tanoue et al. 2005; Luo et al. 2008; Berchtold et al.
2012).
LCB levels in DIR mutants
We observed that nine of 105 protein kinase mutations
resulted in acquired ISP-1 resistance, but the mode of
resistance for these kinase mutants remained unclear.
Therefore, we first attempted to type DIR mutants.
Although ISP-1 depletes multiple molecular species of
sphingolipids, recent progress in the field indicates that
loss of LCBs, rather than downstream complex sphingo-
lipid species, causes lethality (Epstein et al. 2012). We
thus determined basal LCB levels in the DIR mutants
using fluorescence HPLC. The fpk1Δ/dir1 cells exhibited a
statistically significant increase in basal LCB level
(Fig. 1B). Thus, Fpk1 kinase signals attenuated basal LCB
levels. In contrast, other DIR strains did not have signifi-
cantly elevated basal LCB levels, showing that increased
basal LCB expression is not a common mechanism of
ISP-1 resistance in these strains.
We next explored the effects of ISP-1 treatment on cel-
lular LCB levels. When compared to the control strain,
strains with deletions of fpk1Δ/dir1, ctk1Δ/dir3 (Lee and
Greenleaf 1991), and cla4Δ/dir8 (Cvrckova et al. 1995)
retained higher levels of LCBs 3 h after ISP-1 treatment
(Fig. 1B), the time point at which ISP-1 starts to affect
yeast viability (Sun et al. 2000). The weak ISP-1 resistance,
despite the marked restoration of LCB levels in cla4Δ cells,
could be caused by the “slow growth” phenotype of this
strain. Strains with deletions of fpk2Δ/dir2, snf1Δ/dir4,
kin4Δ/dir5, yck1Δ/dir9, ark1Δ/dir10, and akl1Δ/dir11 did
not show significantly altered levels of LCBs, although
there was a tendency toward stronger basal LCB levels in
yck1Δ/dir9 cells. Among these mutants, fpk2Δ/dir2, kin4Δ/
dir5, and ark1Δ/dir10 exhibited very limited resistance, as
compared with the WT control. Thus, it is difficult to
determine whether LCB levels are associated with the
resistance phenotype. Given the stronger resistance levels
of snf1Δ/dir4 (Carlson et al. 1981) and akl1Δ/dir11 (Ta-
kahashi et al. 2006), these kinases may be involved in sig-
naling events downstream of the sphingolipids. Overall,
Dir protein kinases were dispersed in the AGC, CAMK,
CMGC, CK, and STE families within the yeast kinome,
although the AGC protein kinase family was mainly stud-
ied in the context of cellular sphingolipids.
The ISP-1 resistance of DIR mutants was not uniform.
Therefore, resistance could be mediated via several inde-
pendent mechanisms. It has been reported that aureobasi-
din A (AbA), an inhibitor of complex sphingolipid







DIR1 FPK1 AGC, S6K Flippase regulation
DIR2 KIN82/
FPK2
AGC, S6K Flippase regulation
DIR3 CTK1 CMGC C-terminal domain kinase for
RNA pol. II
DIR4 SNF1 CAMK AMPK for glucose starvation signal
DIR5 KIN4 CAMK Inhibits the mitotic exit network,
MEN
DIR8 CLA4 STE PAK (p21-activated kinase) family
DIR9 YCK1 CK1 PM casein kinase I isoform
DIR10 ARK1 ARK/PRK Required for endocytosis
DIR11 AKL1 ARK/PRK Member of the Ark kinase family
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biosynthesis (Fig. S1A), causes yeast cell death, perhaps
due to accumulation of ceramide species with C26 acyl
chains (Nagiec et al. 1997; Epstein et al. 2012). The AbA
resistance spectra of DIR mutants were different from that
of ISP-1 in that resistance was notably weaker in the
fpk1Δ/dir1, yck1Δ/dir9, and akl1Δ/dir11 strains (Fig. S1B).
Therefore, these kinases could have a more direct rela-
tionship with LCB species than ceramides or complex
sphingolipids. The similar resistance of the ctk1Δ/dir3 and
snf1Δ/dir4 strains to ISP-1 and AbA further confirms that
these protein kinases have a distinct mode of resistance to
fpk1Δ/dir1 cells. The LCB-level typing of DIR strains
revealed that ISP-1/aureobasidin A resistance is achieved
by various independent mechanisms; thus, more detailed
analysis is required. Notably, the fpk1Δ/dir1 strain showed
elevated LCB levels regardless of ISP-1 treatment, as well
as the strongest resistance among DIR strains.
Basic characterization of Fpk1/Dir1 and Fpk2/
Dir2
Among the DIR genes, FPK1 and FPK2 encode a homolo-
gous set of protein kinases that may play redundant roles.
We evaluated these genes because both paralogs were
positive in the screening. Indeed, it has been reported that
Fpk1/2 kinases have redundant roles in aminophospholi-
pid flippase regulation (Nakano et al. 2008), and muta-
tion of FPK1 causes ISP-1 resistance (Roelants et al.
2010). Thus, Fpk1/2 kinases are likely associated with cel-
lular lipids. The fpk1/2Δ cells show potent ISP-1 resis-
tance, similar to fpk1Δ cells (Fig. 2A). Unlike our
screening assays (Fig. 1A), the resistance of fpk2Δ was not
apparent in SD medium. In accordance with the deletion
phenotype, overexpression of Fpk1 sensitized yeast cells to
ISP-1 (Fig. 2B), although a kinase-inactive mutant did
not exhibit the same effect (data not shown). Thus, it was
evident that FPK1 gene dosage was negatively correlated
with the strength of ISP-1 resistance. Although LCBs are
essential for yeast viability, supplementation with excess
PHS, a major LCB species in yeast, is cytotoxic (Skrzypek
et al. 1998; Chung et al. 2001). We also examined the
resistance of these cells to PHS to understand its relation-
ship with LCBs. Fpk1 abundance was positively correlated
with resistance to PHS, indicating that cellular LCB levels
are responsible for the phenotype (Fig. 2A and B). Here,
expression of FPK2 exhibited an additive effect. Taken
together, these data suggest that FPK1/2 expression
enhanced the effect of PHS but reduced that of ISP-1;
WT (Kan + HIS3) 
g mL–1)n005(1-PSIlortnoC
WT (Kan + HIS3) 
WT (351 + 352) 
351 + FPK1 
FPK2 + 352 
FPK1 + FPK2 
WT (352)
FPK1







Figure 2. Fpk1/Dir1 and Fpk2/Dir2 in ISP-1
resistance assays. (A) Effect of double deletion.
Single- and double-deletion strains of FPK1/2
were adjusted for genetic background by the
mean of HIS3 and/or KanMx expression from a
single-copy vector as indicated. Auxotrophy-
matched cells were assessed for resistance to
750 ng mL1 ISP-1 or 30 lM PHS on SD
plates. The data shown are representative of
several independent experiments. (B) Effect of
multicopy FPK1/2 expression. Single or double
expression of FPK1/2 through the use of
YEp352/1 multicopy vectors was assessed in
resistance assays, as described in (A).
Auxotrophy of these strains was matched with
empty vector transformation when necessary
(351 and/or 352).
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both results are consistent with the elevated LCB levels of
fpk1Δ cells.
The ISP-1 resistance profile of FPK1 was the opposite
of that of YPK1/SLI2; YPK1 overexpression and deletion
caused ISP-1 resistance and hypersensitivity, respectively.
However, overexpression of Ypk1 did not result in sensiti-
zation to PHS-mediated growth arrest (Y. Yamane-Sando
and H. Takematsu, unpubl. results). It was previously
proposed that Ypk1 could phosphorylate Fpk1, and Fpk1
could phosphorylate Ypk1 (Roelants et al. 2010). How-
ever, the relationships of the Fpk1–Ypk1 signaling axis to
cellular LCB levels and resistance to ISP-1/PHS remain
unclear, and further investigations are required. There-
fore, we re-examined the Fpk1/2-Ypk1 association to
characterize the link between these kinases and LCBs.
Fpk1/2 kinases are responsible for Ypk1
phosphorylation in a sphingolipid-
dependent manner
Ypk1 is a multicopy suppressor of ISP-1-mediated cell
lethality, and Ypk1 phosphorylation could be visualized as
a band-shift in normal SDS-PAGE assays after PHS treat-
ment (Fig. S2A) (Sun et al. 2000). After PHS treatment,
the slow-migrating GST-Ypk1 was excised from the gel
and subjected to trypsinization. By LC-MS/MS analysis,
the only phosphorylated polypeptide fragment identified
had the sequence KGTINPSNSSVVPVRVSYDASSSTSTVR,
corresponding to amino acids 55–82 of Ypk1, and serine
residue 71 (Ser71, underlined) was phosphorylated.
Indeed, this site was one of two candidate phosphorylation
sites proposed in a previous alanine mutation study
(Roelants et al. 2010). Similar to the effect of ISP-1 treat-
ment, knock-in mutation of Ser71 to alanine (Ypk1S71A)
suppressed the mobility shift observed upon PHS treat-
ment, although Ser51 was also proposed as a phosphoryla-
tion site (Fig. S2B). On the basis of these results, we
concluded that Ser71 is the phosphorylation site responsi-
ble for the observed PHS-mediated major mobility shift.
In contrast to previous Ypk1 overexpression experiments
(Roelants et al. 2010), we found that a single-deletion
mutation of either fpk1Δ or fpk2Δ did not attenuate Ypk1
phosphorylation, whereas double-deletion mutation
resulted in loss of the PHS-mediated major shift (Fig.
S2C). We noted that a minor shift was detectable under
this latter condition, indicating that Ypk1 could be phos-
phorylated by another protein kinase(s) in a PHS-depen-
dent manner.
When Fpk1 was visualized by Western blotting using
antiserum raised against the N-terminal portion of the
protein, it appeared as a very broad band, indicating that
Fpk1 itself is a phosphorylated protein (Fig. S2D). One of
the candidate protein kinases is Ypk1. However, overex-
pression of Ypk1 did not affect the smear pattern of Fpk1
phosphorylation (data not shown). In any case, Fpk1
exhibited a stronger phenotype than Fpk2 in all assays.
Therefore, of these two kinases, Fpk1 plays the more
prominent role. On the basis of these results, we subse-
quently focused on Fpk1.
Direct phosphorylation of Ypk1 by Fpk1 in
vitro
We next examined whether Fpk1 could directly phosphory-
late Ypk1 at Ser71. An in vitro kinase assay using GST-Fpk1
immunoprecipitated from yeast cells without substrate
resulted in a broad band of radioactive GST-Fpk1. Thus,
GST-Fpk1 isolated from yeast cells has autophosphorylation
activity (Fig. 3A). When recombinant Ypk1 was added as a
substrate, similar to a previous study (Roelants et al. 2010),
phosphorylation of Ypk1 by Fpk1 was detected. Ypk1 phos-
phorylation by Fpk1 in vitro resulted in the same mobility
shift observed in cells treated with PHS (Fig. 3A). This indi-
cated that sphingolipid-mediated phosphorylation was trig-
gered by Fpk1. We also used the S71A mutant of Ypk1 as the
substrate to determine the significance of the site. Ypk1S71A
phosphorylation in vitro was severely attenuated, and the
resultant shifted band was diminished (Fig. 3A). These data
indicated that Ser71 was the major site of Fpk1-mediated
phosphorylation, and phosphorylation by Fpk1 was suffi-
cient for the observed band-shift. As we observed a faint sig-
nal with the S71A substrate, other less preferred
phosphorylation sites could exist in Ypk1. Potential phos-
phorylation site(s) include Ser51, as suggested previously
(Roelants et al. 2010).
We next determined the effect of PHS on Fpk1 activity
toward Ypk1, because the shifted band was induced in
PHS-treated cells (Fig. S2A). As expected, Fpk1 activity
toward Ypk1 was stimulated by PHS (Fig. 3B). In terms
of the dose-dependency of the effect, the signal appeared
saturated at 20 lM (Fig. 3B). Consistently, autophos-
phorylation of Fpk1 was also increased under these condi-
tions, indicating that PHS can directly activate Fpk1
regardless of the substrate (Fig. 3B). Similar to Ypk1
activity toward Lsp1 or Pil1 (Zhang et al. 2004), a control
amino lipid, stearylamine, also resulted in subtle activa-
tion. However, Fpk1 activity in the presence of PHS was
stronger than under control conditions, which appeared
to be of biological significance (Fig. 3C) as PHS is the
physiological lipid present in cells. We also noted that the
faint, unshifted band was grossly unaffected by PHS
(Fig. 3B). Taken together, our results indicated that Fpk1
is an LCB-activated kinase that preferentially phosphory-
lates Ser71 of Ypk1, resulting in a major mobility shift on
SDS-PAGE, although other minor phosphorylation site(s)
may be present.
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Neither ISP-1 resistance nor duramycin
sensitivity was altered by Ypk1-S71A
mutation
To understand the role of the Fpk1–Ypk1 signaling axis
in ISP-1 resistance, we first evaluated the impact of Ser71
phosphorylation on Fpk1 function. The prediction was
that Fpk1 negatively controls Ypk1-mediated ISP-1 resis-
tance. However, the S71A knock-in mutation did not
affect ISP-1 resistance in either WT or Fpk1/2-overex-
pressing cells (Fig. 4A). Consistently, the PHS sensitiza-
tion phenotype was not altered by S71A mutation of
Ypk1 (Fig. 4A) These observations indicated that Ypk1
phosphorylation by Fpk1 is not involved in the PHS/ISP-
1 resistance phenotype. Therefore, we evaluated other
Fpk1 downstream events. The aminophospholipid flippase
Dnf1/2 has been reported to be regulated by Fpk1/2-med-
iated phosphorylation (Nakano et al. 2008). As duramy-
cin is a cyclic tetrapeptide targeted toward cell-surface
phosphatidylethanolamine (PE), fpk1/2Δ cells were sensi-
tive to duramycin, likely because PE is more abundant on
the surface of cells of this strain (Nakano et al. 2008). We
examined duramycin resistance to examine the involve-
ment of Ypk1 in relation to Fpk1/2 function. Although
Fpk1 phosphorylated Ypk1 at Ser71, the ypk1S71A knock-
in cells did not show altered sensitivity to duramycin
(Fig. 4B); thus Fpk1-mediated phosphorylation of Ypk1 is
not involved in the duramycin resistance. In contrast to
previous findings (Roelants et al. 2010), we did not
observe a loss-of-resistance phenotype in cells that overex-
pressed Ypk1, even when a multicopy vector was used to
drive Ypk1 expression, a condition under which Ypk1
abundance were greatly enhanced (Fig. 4C). In addition,
YPK1 deletion did not confer duramycin resistance as
reported; rather, deletion resulted in increased sensitivity
to duramycin compared to control cells (Fig. 4D). Taken
together, our data did not support Fpk1-mediated Ypk1
suppression or Ypk1-mediated Fpk1 suppression in the
context of resistance toward PHS, ISP-1, or duramycin
under our study conditions. To clarify the difference, we
employed the same resistance assay to that used in the
previous study (Roelants et al. 2010), and used strains
with similar backgrounds. Therefore, differences in the
strains used do not explain the discrepant results. Our
duramycin resistance assay seemed reliable because fpk1/
2Δ cells were consistently sensitive to duramycin (Fig. 4B)
(Nakano et al. 2008). These data may reflect the combi-
nation of the “slow growth and/or compromised cell
wall” phenotype of ypk1Δ cells (Chen et al. 1993) and the
flippase defect of fpk1/2Δ cells (Nakano et al. 2008). To
support this notion, fpk1/2Δ cells, but not ypk1S71A
mutant cells, were resistant to ISP-1 and sensitive to PHS
(Fig. 4A). In conclusion, a functional relationship
between Fpk1-mediated Ser71 phosphorylation of Ypk1
and cell phenotype (susceptibility profiles to PHS, ISP-1,
and duramycin) was not established, although Fpk1/2
kinases do phosphorylate, Ypk1 and Fpk1 activity was
enhanced by the presence of PHS. Therefore, further
explanation of the ISP-1-resistant and PHS-sensitive phe-
notype of fpk1/2Δ cells is necessary.
ISP-1 uptake is regulated by Fpk1/2
If Fpk1/2 is not a negative regulator of Ypk1, some alter-
native pathway must confer ISP-1 resistance upon fpk1/2
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Figure 3. In vitro assay of Fpk1 kinase activity toward Ypk1. (A) The
in vitro kinase assay for Fpk1 utilized recombinant Ypk1 as the
substrate. GST-Fpk1 purified from yeast cells was incubated with a
graded concentration of Ypk1 or the S71A mutant and visualized by
autoradiography after SDS-PAGE. Fpk1 and Ypk1 used in the reaction
were also visualized by Western blotting. Fpk1-mediated
phosphorylation of Ypk1 resulted in a major mobility-shifted band. (B)
Effect of PHS on Fpk1 kinase activity toward Ypk1. Fpk1 activity was
measured in the presence of the indicated concentration of PHS to
examine the effect of LCB on Fpk1 activity. (C) Evaluation of the
effect of PHS. To evaluate PHS-mediated activation of Fpk1,
incorporation of radioactivity into Ypk1 was measured in three
independent experiments. The relative mean radioactivity levels in the
presence of PHS and stearylamine are shown in the columns. The SDE
values of the experiments are indicated as bars on top of the
columns. Student’s t test was used to determine P-values.
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may lead to the formulation of an alternative hypothesis.
Dnf1/2 is an aminophospholipid flippase phosphorylated
by Fpk1/2, and plasma membrane localization of Dnf1/2
is defective in lem3Δ cells (Fig. S3A) (Hanson et al.
2003). Here, we compared the WT control with ypk1S71A
knock-in, fpk1/2Δ, and lem3Δ cells. In the absence of ISP-1,
LCB levels were identical in WT and ypk1S71A cells. PHS
accumulated in fpk1/2Δ cells (Fig. 5A) to a greater extent
than in cells with the single fpk1Δ mutation (Fig. 1B).
Interestingly, the PHS/dihydrosphingosine (DHS) ratio
was skewed in lem3Δ cells without a statistically signifi-
cant alteration in the overall LCB level (Fig. 5A). In con-
clusion, basal LCB levels cannot be attributed to flippase
regulation by Fpk1/2. In contrast to WT and ypk1S71A
cells, both fpk1/2Δ cells and lem3Δ cells were resistant to
LCB depletion upon ISP-1 treatment (Fig. 5A). This was
in agreement with the ISP-1 resistance of triple flippase
mutant cells (Roelants et al. 2010). As lem3Δ cells also
exhibited ISP-1 resistance (Fig. 5B), we examined
whether ISP-1 uptake is regulated by the aminophosphol-
ipid flippase. Fpk1/2 has been reported to negatively reg-
ulate flippase action and induce the inward movement of
aminolipids (Nakano et al. 2008). It is noteworthy that
Dnf1/2 can mobilize phosphatidylcholine, phosphatidyl-
ethanolamine, and phosphatidylserine; this represents a
rather loose specificity for a flippase. ISP-1 consists of an
amino group and a carboxyl group with a hydrophobic
stretch (Fig. S3B), although this structure more closely
resembles that of LCBs than that of phospholipids. Nev-
ertheless, we measured direct ISP-1 uptake from the cul-
ture medium by fpk1/2Δ cells using fluorescence HPLC.
SLI1 encodes an ISP-1 N-acetyltransferase that acetylates
the amino group of the molecule to inactivate its SPT
inhibitor activity (Momoi et al. 2004). As we utilized an
amino group-labeling method to detect cellular ISP-1, we
first assessed the ISP-1 content of ISP-1-treated WT and
sli1Δ cells. As expected, ISP-1 (with the amino group)
levels were higher in sli1Δ cells (Fig. 5C), indicating that
ongoing acetylation by Sli1 obscures ISP-1 detection in
the WT strain in our uptake assay. Therefore, we utilized
the sli1Δ background to accurately measure ISP-1 uptake.
Both lem3Δ and fpk1/2Δ cells showed attenuated uptake
of ISP-1 (Fig. 5C). Therefore, we concluded that Fpk1/2
signals Dnf1/2 to induce ISP-1 uptake, thus altering cellu-
lar resistance to ISP-1. Although our assay does not dis-
criminate whether flippase components are directly
involved in ISP-1 uptake or whether disruption of phos-
pholipid asymmetry in the plasma membrane alters sub-
sequent ISP-1 uptake by modulating cell wall integrity
(Pomorski et al. 2003) or other membrane feature(s).
However, it is clear that regulation of ISP-1 uptake
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Figure 4. Impact of Ser71 phosphorylation of
Ypk1 in ISP-1 and duramycin resistance assays.
(A) Resistance profile of ypk1S71A knock-in
cells. ypk1S71A knock-in cells that harbored the
indicated vectors were assessed for resistance
to ISP-1 and PHS. Vec indicates empty vector
transformants, used to normalize auxotrophy.
(B) Duramycin resistance was measured using
spot assays. Although loss of FPK1/2 resulted
in the sensitization of cells to duramycin, the
knock-in strain of the ypk1S71A mutant was
similar to the WT control. (C) Duramycin
sensitivity was measured in halo assays, and
was indicated by the diameter of the halo
around a drop of duramycin of the indicated
concentration. Halos were not altered in cells
that overexpressed Ypk1 (pYPK1, left).
Western blotting evaluation of Ypk1
overexpression in these strains (right). (D)
Duramycin sensitivity of ypk1Δ cells. Duramycin
sensitivity was evaluated by measuring the
diameter of the halo around a drop of
duramycin in auxotroph-matched WT, ypk1Δ,
and fpk1/2Δ cells. Duramycin sensitivity was
elevated in both ypk1Δ and fpk1/2Δ cells.
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question was how fpk1/2Δ cells increase basal LCB levels
in the absence of ISP-1 (Fig. 5A) and increase sensitivity
to PHS (Fig. 4A), both of which are ISP-1-independent
phenotypes. We hypothesize that these kinases also nega-
tively regulate basal LCB levels.
Transcriptome analysis of fpk1/2Δ cells
To elucidate the function(s) of Fpk1/2, we compared the
transcriptomes of WT and fpk1/2Δ cells using DNA micro-
arrays. The fpk1/2Δ cells suppressed gene expression of the
functionally major type of sphingosine kinase, LCB4, and
the sphingosine-1-phosphate lyase, DPL1 (Table 2). As
both of these genes encode enzymes involved in the LCB
degradation pathway (Fig. S4A), simultaneous repression
of these two genes is expected to result in the intracellular
accumulation of nonphosphorylated forms of LCBs. In this
respect, it has been reported that lcb4/dpl1Δ cells lack
detectable levels of LCB phosphates and that LCB levels are
more than 10-fold higher in lcb4/dpl1/ysr2Δ cells (Kim et al.
2000). Moreover, single deletion of LCB4 was shown to
result in a ca. fourfold increase in LCBs (Ferguson-Yankey
et al. 2002) (Sano et al. 2005). This indicates that phos-
phorylation of LCBs by Lcb4 is the rate-limiting step in the
LCB degradation pathway (Iwaki et al. 2007). Therefore,
cooperative downregulation of degradation pathway
enzymes could explain the increase in LCB levels and in
PHS sensitivity in fpk1/2Δ cells. Consistent with the tran-
scriptional changes, the abundance of Lcb4 was attenuated
as determined by Western blotting (Fig. 5D). Under these
conditions, phosphorylation of Lcb4 remained unchanged,
in agreement with a previous report that Pho85 is the pro-
tein kinase responsible for Lcb4 phosphorylation (Iwaki
et al. 2005). Dnf1/2 flippase function is dispensable for
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Figure 5. LCB levels are increased in the fpk1/2Δ mutant. (A) LCB levels in fpk1/2Δ cells. LCB levels were measured in the indicated mutant
strains before and after ISP-1 treatment in YPD medium as in Figure 1B. LCB levels were measured by HPLC, and the values in the columns
indicate the mean levels of C18-PHS and C18-DHS with SDE values from three independent experiments. *P < 0.01, compared to the WT control
for each condition, as evaluated using Student’s t test. (B) ISP-1 resistance assay for lem3Δ cells. The ISP-1 resistance assay was carried out as
described in Figure 1A using auxotrophy-matched WT, fpk1/2Δ, and lem3Δ strains. (C) ISP-1 uptake by fpk1/2Δ or lem3Δ cells in the sli1Δ
background. The indicated cells were treated with 500 ng mL1 ISP-1 for 1.5 h, and ISP-1 uptake was measured by fluorescence HPLC, as
described in Experimental Procedures. The relative mean ISP-1 levels in three independent experiments are plotted. The statistical significance of
differences was evaluated using Student’s t test. (D) Lcb4 suppression in fpk1/2Δ cells. Lysates were prepared from cells in log phase, and
Western blotting was carried out as described in Figure 3C. The membrane was probed with antiserum against Lcb4 or Pgk1 (left). The graph on
the right shows the relative abundance of Lcb4 from three independent experiments. The statistical significance of differences was evaluated
using Student’s t test. (E) Resistance of flippase-deficient cells could be affected by FPK1 overexpression. Control or lem3Δ/sli1Δ cells that
harbored the indicated vectors were assessed for resistance to ISP-1. pRS416 empty vector transformants were used to normalize auxotrophy. Vec
indicates the empty vector for FPK1 overexpression.
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Lcb4 expression regulation as Lcb4 abundance was not
altered in the lem3Δ strain (Fig. S4B), in which total LCB
levels were unchanged but showed an increased ratio of
PHS to DHS (Fig. 5A). To determine whether minor differ-
ences in LCBs in fpk1/2Δ could alter the ISP-1-resistant
phenotype, we examined loss of ISP-1 resistance in Fpk1-
overexpressing strains utilizing the lem3Δ/sli1Δ strain as a
genetic background. This strain was used to eliminate the
functions of flippase; that is, ISP-1 uptake (lem3Δ) and ISP-
1 inactivation (sli1Δ). Indeed, pFPK1-mediated loss of resis-
tance was detected in the flippase-deficient strain (Fig. 5E).
Therefore, relatively minor changes in LCBs can cause phe-
notypic changes in the resistance assay. On the basis of
these results, we concluded that transcriptional regulation
of the LCB degradation pathway is affected by a signaling
event downstream of Fpk1/2. Currently, the transcriptional
factor(s) involved in regulating this transcriptomic change
downstream of Fpk1/2, thereby enhancing LCB degrada-
tion, remain(s) to be identified. It is interesting to speculate
that the Fpk1/2 kinases function to sense LCB levels, as
Fpk1/2 activities seem to be modulated in vitro by the addi-
tion of PHS (Fig. 3B). Identification of such an Fpk1/2 sub-
strate could provide an understanding of LCB homeostasis.
Microarray experiments also showed that the genes
encoding enzymes involved in complex-type sphingoli-
pids, that is, CSG1, IPT1, AUR1, and ELO2, were upregu-
lated (Fig. S4A), whereas the expression levels of the
genes encoding the ceramide synthase subunits were not
altered. Irrespective of the putative upregulation of these
enzymes, de novo biosynthesis of complex-type sphingoli-
pids was not significantly altered in fpk1/2Δ cells (Fig.
S4C). In accordance with these findings, de novo biosyn-
thesis of sphingolipids was more strongly affected by
incorporation of serine into the pathway than actual SPT
activity (Cowart and Hannun 2007). Alternatively, com-
plex-type sphingolipids and LCBs may be regulated inde-
pendently, albeit not exclusively. In agreement with this
notion, the ceramide band was somewhat weaker in only
fpk1/2Δ cells in de novo labeling experiments with radio-
active serine (Fig. S4C).
In addition to the sphingolipid-related enzyme genes,
our microarray comparison also detected induction of the
BAP2 gene, which encodes a branched amino acid perme-
ase. Western blotting revealed that Bap2 abundance was
increased in fpk1/2Δ cells (Fig. S4D). Thus, Fpk1/2 may
control cellular uptake of branched amino acids. Another
notable finding in the microarray results was that fpk1/2Δ
cells repressed SNF1/DIR4, Snf1 substrate, and many ribo-
some-related genes (Table S2) (Breeden and Nasmyth
1987). Therefore, signaling downstream of Fpk1/2 may
involve complex intracellular events, such as ribogenesis
or nutrient uptake, which may be affected by the avail-
ability of glucose or amino acids. Our DIR screening sug-
gested that Snf1, the yeast homolog of the AMP-activated
protein kinase family, could be involved in sphingolipid-
mediated signaling pathways. Indeed, recent systems bio-
logical approaches utilizing gene ontology annotations
suggested a potential relationship between Snf1 and cellu-
lar sphingolipids, and showed that deletion of the SNF1
gene could cause ISP-1 resistance (Yucel and Ulgen
2013). This report listed 15 other genes – including two
DIV and three DIR genes (including SNF1) – possibly
involved in the context of cellular sphingolipids. Although
SNF1 was the only gene exceeding the twofold threshold
in fpk11/2Δ DNA microarray analyses, the expression of
SCS7 and CSG2 (among the 16 genes listed) was also
increased by roughly 1.5-fold in fpk1/2Δ cells (data not
shown). Therefore, some of the listed genes seem to be
related to cellular sphingolipids regulated by Fpk1/2.
Functional assessment of a mammalian
kinase of the S6K/RSK family
Fpk1 and Fpk2 belong to the AGC kinase family and
exhibit sequence similarities to S6K/RSK family protein
kinases (Fig. S5A). Although Fpk1/2 proteins align with
p60-S6 kinases (S6K), a functional counterpart of S6K,
Sch9, has been reported in yeast (Urban et al. 2007). The
transcriptomic data indicated that one of the events
downstream of Fpk1/2 could involve the biosynthesis of
ribosomes (Table S2). In any case, Fpk1/2 kinases could
be functionally conserved in mammals. Therefore, func-
tional assays were used to characterize relationships
Table 2. Transcriptomic analysis of fpk1/2Δ cells.
Systemic
name Gene name Description
Fold-expression
(fpk1Δfpk2Δ/wt)
YBR068C BAP2 High-affinity leucine
permease
3.51
YDR072C IPT1 M(IP)2C synthase 2.67
YKL004W AUR1 IPC synthase 2.49
YCR034W FEN1/ELO2 Fatty acid elongase 2.48
YPL057C SUR1 MIPC synthase subunit 2.02
YOR171C LCB4 Sphingoid long-chain
base kinase
0.24
YDR477W SNF1/DIR4 AMPK catalytic subunit 0.39
YDR208W MSS4/SLI6 PhosIns 4-P 5 kinase 0.40






Genes that showed a ≥ twofold increase or decrease in expression in
the fpk1/2Δ cells were identified by competitive two-color hybridiza-
tion assay using the cDNA microarray. Sorted genes of interest are
listed here; a full array-wide list of genes is presented in Table S2.
Each gene is listed with the ORF name, gene name, brief description,
and fold-difference in expression, as compared to the control.
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between human and yeast genes (Fig. S5A). As intracellu-
lar Fpk1/2 functionality could be measured using the ISP-
1 resistance assay in yeast cells, we evaluated eight protein
kinases of mammalian origin (Fig. S5B). When expressed
in fpk1/2Δ cells, only RPS6KA2/p90-RSK3 (RSK3) rescued
the fpk1/2Δ phenotype with respect to both ISP-1 and
PHS (Fig. 6A and B) despite PRKX and PRKY exhibiting
greater sequence similarity. As expected from the lack of
a resistance phenotype of the ypk1S71A mutant, RSK3
expression did not rescue the Ypk1 Ser71 phosphorylation
defect of fpk1/2Δ (Fig. S5C). These results further indicate
that the Fpk1–Ypk1 phosphorylation axis is distinct from
the ISP-1 resistance activity of fpk1/2Δ cells. Currently,
the physiological significance of the Fpk1–Ypk1 branch
remains to be clarified, although it is clear that Fpk1 does
not negatively regulate Ypk1. Identification of the specific
substrate(s) affected by the ypk1S71A knock-in mutation
may reveal its significance, as point mutations could affect
specific downstream events (Tanoue et al. 2005). Our
results indicate that mammalian cells retain a functionally
equivalent kinase in their kinome in the RSK3 of the p90-
S6K/RSK family, which was previously suggested to func-
tion downstream of MAP kinase signaling (Bignone et al.
2007). To determine the Fpk1 function (LCB degradation
or flippase regulation) that is complemented by RSK3, we
examined the LCB profiles of these cells in the absence of
ISP-1. RSK3 expression suppressed LCB levels that were
increased by fpk1/2 deletion (Fig. 6C). We found that
RSK3 is likely the functional counterpart to Fpk1, regulat-
ing LCB degradation rather than ISP-1 uptake to confer
ISP-1 resistance (Fig. S6A).
Concluding Remarks
In this study, we isolated DIR genes to gain insight into
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Figure 6. Assessment of a mammalian counterpart of FPK1/2. ISP-1 resistance of human cDNA-expressing WT (A) and fpk1/2Δ (B) cells. The
assay for resistance to ISP-1 or PHS was carried out as described in Figure 2A. Human protein kinase cDNA was expressed using a multicopy
YEp352 vector harboring the promoter and terminator of the ADH1 gene. (C) LCB level of RPS6KA2/RSK3-expressing cells. The basal levels of
LCBs in the indicated cells everexpressing Fpk1 or RSK3 cultured in SD medium (to retain the plasmid) were quantified as shown in Figure 1B.
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lism/signaling. We show here for the first time that the
Fpk1/2 (Dir1/2) proteins have dual functions in terms of
regulating ISP-1 uptake and LCB degradation (Fig. 5).
This seems to explain the robust ISP-1 resistance of fpk1/
2Δ cells (Fig. S6A). The function of Fpk1/2 is not limited
to cell survival in response to compound treatment.
Rather, Fpk1/2 also functions to maintain cellular LCB
levels and enable signaling (Fig. S6B), which appeared to
be evolutionarily conserved.
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Figure S1. Proliferation of DIR strains after inhibition of
sphingolipid biosynthesis. (A) Sphingolipid biosynthetic
pathways in yeast. The biosynthetic pathway of sphingoli-
pids is shown schematically. Inhibitors used in this study are
shown in blue. Molecular species of the sphingoid long-
chain bases (LCBs) and complex sphingolipids are indicated
on the left. (B) Aureobasidin A resistance of DIR strains
based on the results of spot assays. Spot assays were per-
formed as described in Figure 1A, except that a YPD-aureo-
basidin A (AbA, 40 ng mL1) plate was used.
Figure S2. Sphingolipid-mediated phosphorylation of Ypk1
is mediated by the Fpk1/2 kinases. (A) Purification of PHS-
treated Ypk1. Recombinant Ypk1 conjugated to a GST-tag
was purified from yeast cells that harbored pEG (KG), and
the protein was resolved by SDS-PAGE and stained with
Coomassie brilliant blue. The mobility-shifted bands
(arrowheads) were excised from the gel and subjected to
MALDI-TOF/MS-MS analysis to identify phosphorylation
sites. (B) Evaluation of PHS-induced Ser71 phosphoryla-
tion. A lysate of nontagged endogenous/knock-in Ypk1 was
assessed by Western blotting after PHS or ISP-1 treatment.
Upon PHS treatment, WT Ypk1 accumulated the phosphor-
ylated species, whereas the Ypk1S71A mutant did not. (C)
Effect of Fpk1/2 expression on sphingolipid-induced phos-
phorylation of endogenous Ypk1. Cells that carried a single
deletion of FPK1 or FPK2 or a double mutation were com-
pared withWT cells. Auxotrophy of each strain was matched
with KanMx/HIS3 vector transformation. Cells treated with
PHS or ISP-1 were evaluated. Fpk1 and Ypk1 were visualized
using specific antisera. Pgk1 was employed as a control. The
arrowhead indicates the minor shift of the Ypk1 band in
fpk1/2D cells. (D) Basal phosphorylation of Fpk1. Cell lysates
were treated with calf intestinal phosphatase (CIP) and eval-
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uated by Western blotting. The mobility of the Fpk1 band
increased upon phosphatase digestion, indicating that Fpk1
is a phosphoprotein.
Figure S3. Flippase regulation by Fpk1/2. (A) Effects of
Lem3 on flippase expression: Dnf1/2 is complexed with
Lem3 in the endoplasmic reticulum to sort Dnf1/2 to the
plasma membrane. Therefore, lem3D cells fail to express
active Dnf1/2 complex on the plasma membrane. (B) Struc-
tures of the flippase Dnf1/2 substrates PC, PS, PE, and ISP-1.
Figure S4. Transcriptomic analyses 1 of the fpk1/2D cells.
(A) Biosynthetic pathway for sphingolipids in budding
yeast. The species of sphingolipids are connected with
arrows that represent the enzymatic reactions responsible.
Colored arrows represent downregulated (blue) or upregu-
lated (red) enzyme genes in fpk1/2D cells, as compared with
the WT cells based on the results of cDNA microarray
analysis. Full microarray data have been submitted to the
GEO database under submission number GSE42083. (B)
Examination of the role of flippase in Lcb4 expression. Lcb4
abundance was determined based on Western blotting
experiments, as in Figure 5D. Lcb4 signal in flippase-defi-
cient lem3D cells was compared with WT control (left).
Band intensities were calculated from three independent
experiments and are shown as mean values of differences
relative to control cells (right). Bars in each graph represent
SDE among experiments. WT and lem3D expressed similar
levels of Lcb4, indicating that flippase regulation of Fpk1/2
is dispensable for Lcb4 expression. (C) Assessment of de
novo biosynthesis of complex-type sphingolipids. Cells of
each genotype were metabolically labeled with [3H]-serine
with ISP-1. The lipid fractions were isolated and separated
using thin layer chromatography. Radioactivity was detected
in the BAS-2500 using a tritium plate. Sphingolipid species
are indicated. (D) Analysis of Bap2 expression. BAP2
encodes a branched amino acid permease. Bap2 expression
was monitored in the cells of the indicated genotypes using
Western blotting. Pgk1 was utilized as a loading control.
Figure S5. Assessment of a mammalian functional counter-
part of FPK1/2. (A) Sequence similarities among the indi-
cated AGC kinases from humans and budding yeasts are
expressed in a phylogenetic tree using ClustalW software.
(B) ISP-1 resistance of human cDNA-expressing WT cells.
The assay for resistance to ISP-1 or PHS was performed as
described in Figure 2A, except that the WT was used.
Human protein kinase cDNA was expressed using a multi-
copy vector with the ADH1 promoter. (C) PHS-mediated
Ypk1 phosphorylation in human kinase cDNA-expressing
cells. Western blotting was performed as shown in Figure
S2B. Recovery of Ser71 phosphorylation (causing slow
migration) of Ypk1 was assessed with PHS. None of the
human kinases recovered Ser71 phosphorylation in the
fpk1/2D background. This result indicated that Ser71 phos-
phorylation is independent of ISP-1 resistance.
Figure S6. Schematic presentation of Fpk1/2 function in
relation 1 to cellular LCBs. (A) Putative role of Fpk1/2 in
LCB suppression Fpk1/2 regulates the phosphorylation of
Dnf1/2 to control ISP-1 uptake. Fpk1/2 also regulated
LCB4 expression to control LCB degradation. A combina-
tion of these two events is responsible for the robust dele-
tion-mediated ISP-1 resistance of fpk1/2D cells. In addition,
Fpk1/2 control phosphorylation of Ypk1 at Ser71, although
downstream events remain unclear. (B) Possible homeo-
static balancing of cellular LCB levels. Previous studies
showed that Orm1/2 control cellular LCB levels by interact-
ing with SPT. Orm1/2 can be phosphorylated by Ypk1,
which thus could control SPT activity. Pkh1/2-mediated
phosphorylation of the activation loop on Ypk1 is impor-
tant for Ypk1 activity, and Pkh1/2 activity could be stimu-
lated in an LCB-dependent manner. A combination of
these mechanisms could form a positive-feedback loop
rather than negative-feedback to maintain LCB levels,
which would play a role in induction. Fpk1/2 is also an
AGC kinase, which requires activation-loop phosphoryla-
tion. Therefore, Pkh1/2 could be involved in the Fpk1/2
branch. Our results suggested that Fpk1/2 could be stimu-
lated by LCBs and suppress the degradation pathway of
LCBs. This pathway is likely involved in homeostatic bal-
ancing of LCB levels.
Table S1. Screening for DIR/DIV genes.
Table S2. Transcriptome analysis of fpk1/2D cells.
Table S3. Genotypes of the yeast strains used in this study.
Table S4. Plasmids used in this study.
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